Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
British Journal of Clinical Pharmacology|January 1, 1983
Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjectsG L Shepherd, P J Lewis, I A Blair, et al.
British Journal of Clinical Pharmacology|June 1, 1976
Pharmacokinetics of indoramin in manG H Draffan, P J Lewis, J L Firmin, et al.
Prostaglandins|November 1, 1979
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometryC N Hensby, G A Fitzgerald, L A Friedman, et al.
Clinical Pharmacology and Therapeutics|November 1, 1983
Oral absorption and concentration-effect relationship of tyramine with and without cimoxatone, a type-A specific inhibitor of monoamine oxidaseC T Dollery, M J Brown, D S Davies, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1986
Rapid reversal of ergotamine-induced vasospasmP J Lewis, T W Noseworthy, A A Fitzgerald, et al.
Prostaglandins and Medicine|June 1, 1981
Forearm ischaemia as a test of prostacyclin production: studies in normal subjects and in patients with diabetes mellitusJ Webster, P J Lewis, J MacDermot, et al.
Prostaglandins|April 1, 1982
Prostacyclin is not a circulating hormone in manI A Blair, S E Barrow, K A Waddell, et al.
Annals of Clinical Research|January 1, 1985
Potassium supplementation fails to lower blood pressure in hypertensive patients receiving a potassium losing diureticC J Bulpitt, G Ferrier, P J Lewis, et al.
Pageof 14